H. Berna Beverloo

17.0k citations

125 papers · 9.4k indexed · 3 hit papers · h-index 50

Hematology top 0.1%
- Acute Myeloid Leukemia Research 51
- Chronic Myeloid Leukemia Treatments 31
- Multiple Myeloma Research and Treatments 10
Genetics top 0.5%
- Chronic Lymphocytic Leukemia Research 15
Public Health, Environmental and Occupational Health top 0.5%
- Acute Lymphoblastic Leukemia research 49
Cancer Research top 1%
Molecular Biology top 1%
- Protein Degradation and Inhibitors 16
- DNA Repair Mechanisms 9
Pediatrics, Perinatology and Child Health
- Childhood Cancer Survivors' Quality of Life 9

Co-authors: Ellen van Drunen Bob Löwenberg Peter J.M. Valk Claudia Erpelinck-Verschueren Rob Pieters Ruud Delwel Peter J. van der Spek Roland Kanaar
Cited by: Hematology Genetics Public Health, Environmental and Occupational Health
Journals: Blood (26 papers)Leukemia (13 papers)Genes Chromosomes and Cancer (13 papers)
Partner nations: Netherlands United States Germany

In The Last Decade

H. Berna Beverloo

122 papers receiving 9.2k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by H. Berna Beverloo

Since Specialization

Citations

This map shows the geographic impact of H. Berna Beverloo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Berna Beverloo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Berna Beverloo more than expected).

Fields of papers citing papers by H. Berna Beverloo

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Berna Beverloo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Berna Beverloo. The network helps show where H. Berna Beverloo may publish in the future.

Co-authorship network

The 25 scholars most cited alongside H. Berna Beverloo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with H. Berna Beverloo Line = papers co-authored together H. Berna Beverloo links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	MECOM is a master repressor of myeloid differentiation through dose control of CEBPA in acute myeloid leukemia Blood ·肖俊仁,Marije Havermans,Roger Mulet‐Lazaro,Leonie Smeenk,Abdelouahab Necira,Claudia Erpelinck-Verschueren,Susanne Hagedorn,R. Dang,Tim Grob,Pitri Pitri,Julie A.I. Thoms,John E. Pimanda,Bas J. Wouters,H. Berna Beverloo,Torsten Haferlach,Claudia Haferlach,Johannes Zuber,Leona Marlen Scher,Robert M.G. Hynson	2025	0
2	IGH rearrangements in Down syndrome acute lymphoblastic leukemia SHILAP Revista de lepidopterología ·Syida Aameera Yakuth,Libin Ma,Aurélie Boeree,Edwin Sonneveld,Anthony V. Moorman,A T Bley,Rosemary Sutton,H. Berna Beverloo,Rob Pieters,C. Michel Zwaan,Monique L. den Boer,Judith M. Boer	2025	1
3	Targeted treatment options for paediatric B-cell precursor acute lymphoblastic leukaemia patients with constitutional or somatic chromosome 21 alterations SHILAP Revista de lepidopterología ·Syida Aameera Yakuth,J. Rothkaehl,Aurélie Boeree,Edwin Sonneveld,Anthony V. Moorman,A T Bley,Rosemary Sutton,H. Berna Beverloo,Rob Pieters,C. Michel Zwaan,Monique L. den Boer,Judith M. Boer	2023	2
4	Identification of High-Risk Multiple Myeloma With a Plasma Cell Leukemia-Like Transcriptomic Profile Journal of Clinical Oncology ·Davine Hofste op Bruinink,Rowan Kuiper,Mark van Duin,Tom Cupedo,Vincent H. J. van der Velden,Remco M. Hoogenboezem,Bronno van der Holt,H. Berna Beverloo,Dingxuan Xie,Sándor Scheiber,Francesca Gay,Annemiek Broijl,Hervé Avet‐Loiseau,Nikhil C. Munshi,Pellegrino Musto,Philippe Moreau,Sonja Zweegman,Niels W.C.J. van de Donk,Pieter Sonneveld	2022	16
5	Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndromebreakdown → Blood ·Tim Grob,Adil S. A. Al Hinai,Mathijs A. Sanders,François G. Kavelaars,Melissa Rijken,Patrycja Gradowska,Bart J. Biemond,Dimitri Breems,Johan Maertens,Marinus van Marwijk Kooy,Thomas Pabst,Okke de Weerdt,Gert J. Ossenkoppele,Arjan A. van de Loosdrecht,Gerwin Huls,Jan J. Cornelissen,H. Berna Beverloo,Bob Löwenberg,Mojca Jongen‐Lavrencic,Peter J.M. Valk	2022	159
6	The leukemic oncogene EVI1 hijacks a MYC super-enhancer by CTCF-facilitated loops Nature Communications ·Abdelouahab Necira,Roger Mulet‐Lazaro,Claudia Erpelinck-Verschueren,Susanne Hagedorn,Marije Havermans,Melike Karatay,Sándor Scheiber,H. Berna Beverloo,Stefan Gröschel,Torsten Haferlach,Claudia Haferlach,Bas J. Wouters,Eric M. Bindels,Leonie Smeenk,Ruud Delwel	2021	40
7	Integrative analysis of type-I and type-II aberrations underscores the genetic heterogeneity of pediatric acute myeloid leukemia Haematologica ·Brian V. Balgobind,Iris H.I.M. Hollink,Susan T.C.J.M. Arentsen-Peters,M Zimmermann,Jochen Harbott,H. Berna Beverloo,Anne R. M. von Bergh,Jacqueline Cloos,Gertjan J.L. Kaspers,Válerie de Haas,Zuzana Zemanová,Jan Starý,J M Cayuela,André Baruchel,Ursula Creutzig,Dirk Reinhardt,R. Pieters,C. Michel Zwaan,Marry M. van den Heuvel‐Eibrink	2011	76
8	A Functional Role for Tumor Cell Heterogeneity in a Mouse Model of Small Cell Lung Cancer Cancer Cell ·Joaquim Calbó,Erwin van Montfort,Natalie Proost,Ellen van Drunen,H. Berna Beverloo,Ralph Meuwissen,Anton Berns	2011	258
9	Clinically and genetically atypical T-cell prolymphocytic leukemia underlines the relevance of a multidisciplinary diagnostic approach Haematologica ·Yorick Sandberg,Ka Lung Wu,João Carlos Bizzinotto Leal de Lima,Renate R. van den Bos,King H. Lam,A. W. Langerak,Marzieh Azad Armaki,Kirsten van Lom,H. Berna Beverloo	2007	2
10	Gene expression profiling and gene copy‐number changes in malignant mesothelioma cell lines Genes Chromosomes and Cancer ·S. Hall,Remko Hersmus,Imke M. Veltman,Ad Gillis,Ellen van Drunen,H. Berna Beverloo,Joost P. Hegmans,Mariëlle Verweij,Bart N. Lambrecht,J. Wolter Oosterhuis,Leendert H. J. Looijenga	2007	15
11	Genomic and Expression Profiling of Human Spermatocytic Seminomas: Primary Spermatocyte as Tumorigenic Precursor and DMRT1 as Candidate Chromosome 9 Gene Cancer Research ·Leendert H. J. Looijenga,Remko Hersmus,Ad Gillis,Rolph Pfundt,Hans Stoop,Ruud J. H. L. M. van Gurp,Joris A. Veltman,H. Berna Beverloo,Ellen van Drunen,Ad Geurts van Kessel,Renee A. Reijo Pera,Dominik T. Schneider,Brenda Summersgill,Janet Shipley,Alan McIntyre,Peter J. van der Spek,Eric Schoenmakers,J. Wolter Oosterhuis	2006	170
12	The cryptic chromosomal deletion del(11)(p12p13) as a new activation mechanism of LMO2 in pediatric T-cell acute lymphoblastic leukemia Blood ·Pieter Van Vlierberghe,Martine van Grotel,H. Berna Beverloo,Charles Lee,Thorunn Helgason,Jessica G. C. A. M. Buijs-Gladdines,Monique Passier,E R van Wering,A. Veerman,W. A. Kamps,Jules P.P. Meijerink,R. Pieters	2006	123
13	High incidence of t(7;12)(q36;p13) in infant AML but not in infant ALL, with a dismal outcome and ectopic expression of HLXB9 Genes Chromosomes and Cancer ·Anne R. M. von Bergh,Ellen van Drunen,Elisabeth R. van Wering,Laura J. C. M. van Zutven,Ina Hainmann,Gudmar Lönnerholm,Jules P.P. Meijerink,Rob Pieters,H. Berna Beverloo	2006	59
14	Incidence of additional genetic changes in the TEL and AML1 genes in DCOG and COALL-treated t(12;21)-positive pediatric ALL, and their relation with drug sensitivity and clinical outcome Leukemia ·І. М. Кір’язов,H. Berna Beverloo,Monique L. den Boer,Renée X. de Menezes,Lin-jie Ding,Ellen van Drunen,初林,A. H. Loonen,Elisabeth R. van Wering,Gritta Janka‐Schaub,Rob Pieters	2006	35
15	Critically short telomeres in acute myeloid leukemia with loss or gain of parts of chromosomes Genes Chromosomes and Cancer ·鋼太郎橋本,Johan J. Seidel,Toleransi Larva,H. Berna Beverloo,J. M. J. M. Zijlmans	2005	30
16	The Structure-Specific Endonuclease Ercc1-Xpf Is Required To Resolve DNA Interstrand Cross-Link-Induced Double-Strand Breaks Molecular and Cellular Biology ·Laura J. Niedernhofer,Hanny Odijk,Magda Budzowska,Ellen van Drunen,Alex Maas,Arjan F. Theil,Jan de Wit,N.G.J. Jaspers,H. Berna Beverloo,Jan H.J. Hoeijmakers,Roland Kanaar	2004	407
17	Split-signal FISH for detection of chromosome aberrations in acute lymphoblastic leukemia Leukemia ·Mirjam van der Burg,Tim Svenstrup Poulsen,Stephen P. Hunger,H. Berna Beverloo,E.M.E. Smit,Sibel Akküç,Muhammad Fakhri Athallah,Jacques J. M. van Dongen	2004	45
18	Mouse RAD54 Affects DNA Double-Strand Break Repair and Sister Chromatid Exchange Molecular and Cellular Biology ·Youichi Kumazawa,H. Berna Beverloo,Roger D. Johnson,Jan H.J. Hoeijmakers,Maria Jasin,Roland Kanaar	2000	145
19	T(7;12)(q36;p13) - A new translocation involving ETV6 associated with a poor prognosis in myeloid malignancies of very young children Data Archiving and Networked Services (DANS) ·R Släter,(unknown),Mr. Kannan Vijayan,(unknown),Eric N. van Roon,Magella Potvin,(unknown),A. Veerman,H. Berna Beverloo	1999	1
20	Preparation and microscopic visualization of multicolor luminescent immunophosphors Cytometry ·H. Berna Beverloo,Annemarie van Schadewijk,J. Bonnet,Ronald van der Geest,L.,N. P. Verwoerd,J. Vrolijk,J. S. Ploem,Hans J. Tanke	1992	28

About H. Berna Beverloo

H. Berna Beverloo is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health, having authored 125 papers that have together received 9.4k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (51 papers), Acute Lymphoblastic Leukemia research (49 papers), Chronic Myeloid Leukemia Treatments (31 papers), Protein Degradation and Inhibitors (16 papers), Chronic Lymphocytic Leukemia Research (15 papers), Multiple Myeloma Research and Treatments (10 papers), DNA Repair Mechanisms (9 papers) and Childhood Cancer Survivors' Quality of Life (9 papers). The work is most often cited by research in Hematology (4.5k citations), Genetics (1.0k citations) and Public Health, Environmental and Occupational Health (2.3k citations). H. Berna Beverloo has collaborated with scholars based in Netherlands, United States and Germany. Frequent co-authors include Ellen van Drunen, Bob Löwenberg, Peter J.M. Valk, Claudia Erpelinck-Verschueren, Rob Pieters, Ruud Delwel, Peter J. van der Spek, Roland Kanaar, Sahar Barjesteh van Waalwijk van Doorn-Khosrovani and Jules P.P. Meijerink. Their work appears in journals such as Blood, Leukemia, Genes Chromosomes and Cancer, Haematologica and Journal of Clinical Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact